BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22124121)

  • 1. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
    Liu SM; Sutherland AP; Zhang Z; Rainbow DB; Quintana FJ; Paterson AM; Sharpe AH; Oukka M; Wicker LS; Kuchroo VK
    J Immunol; 2012 Jan; 188(1):155-62. PubMed ID: 22124121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.
    Stumpf M; Zhou X; Bluestone JA
    J Immunol; 2013 Feb; 190(3):961-9. PubMed ID: 23293354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
    Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
    Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
    Ichinose K; Zhang Z; Koga T; Juang YT; Kis-Tóth K; Sharpe AH; Kuchroo V; Crispín JC; Tsokos GC
    Arthritis Rheum; 2013 Mar; 65(3):764-9. PubMed ID: 23203389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
    Paterson AM; Lovitch SB; Sage PT; Juneja VR; Lee Y; Trombley JD; Arancibia-Cárcamo CV; Sobel RA; Rudensky AY; Kuchroo VK; Freeman GJ; Sharpe AH
    J Exp Med; 2015 Sep; 212(10):1603-21. PubMed ID: 26371185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
    Zeissig S; Petersen BS; Tomczak M; Melum E; Huc-Claustre E; Dougan SK; Laerdahl JK; Stade B; Forster M; Schreiber S; Weir D; Leichtner AM; Franke A; Blumberg RS
    Gut; 2015 Dec; 64(12):1889-97. PubMed ID: 25367873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
    Schubert D; Bode C; Kenefeck R; Hou TZ; Wing JB; Kennedy A; Bulashevska A; Petersen BS; Schäffer AA; Grüning BA; Unger S; Frede N; Baumann U; Witte T; Schmidt RE; Dueckers G; Niehues T; Seneviratne S; Kanariou M; Speckmann C; Ehl S; Rensing-Ehl A; Warnatz K; Rakhmanov M; Thimme R; Hasselblatt P; Emmerich F; Cathomen T; Backofen R; Fisch P; Seidl M; May A; Schmitt-Graeff A; Ikemizu S; Salzer U; Franke A; Sakaguchi S; Walker LSK; Sansom DM; Grimbacher B
    Nat Med; 2014 Dec; 20(12):1410-1416. PubMed ID: 25329329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous colitis occurrence in transgenic mice with altered B7-mediated costimulation.
    Kim G; Turovskaya O; Levin M; Byrne FR; Whoriskey JS; McCabe JG; Kronenberg M
    J Immunol; 2008 Oct; 181(8):5278-88. PubMed ID: 18832683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
    Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells.
    Kawashima H; Takatori H; Suzuki K; Iwata A; Yokota M; Suto A; Minamino T; Hirose K; Nakajima H
    J Immunol; 2013 Oct; 191(7):3614-23. PubMed ID: 24006461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.
    Araki M; Chung D; Liu S; Rainbow DB; Chamberlain G; Garner V; Hunter KM; Vijayakrishnan L; Peterson LB; Oukka M; Sharpe AH; Sobel R; Kuchroo VK; Wicker LS
    J Immunol; 2009 Oct; 183(8):5146-57. PubMed ID: 19783679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4: From mechanism to autoimmune therapy.
    Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B
    Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-faceted inhibition of dendritic cell function by CD4
    Seitz C; Liu S; Klocke K; Joly AL; Czarnewski PV; Tibbitt CA; Parigi SM; Westerberg LS; Coquet JM; Villablanca EJ; Wing K; Andersson J
    J Autoimmun; 2019 Mar; 98():86-94. PubMed ID: 30616979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function.
    Stumpf M; Zhou X; Chikuma S; Bluestone JA
    Eur J Immunol; 2014 Jun; 44(6):1737-46. PubMed ID: 24648182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo.
    Joly AL; Liu S; Dahlberg CI; Mailer RK; Westerberg LS; Andersson J
    J Autoimmun; 2015 Sep; 63():23-30. PubMed ID: 26149776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.